Impact of peri-procedural management of direct oral anticoagulants on pocket haematoma after cardiac electronic device implantation: the StimAOD multicentre prospective study.
Anne-Céline MartinOrianne WeizmanJean Marc SellalVincent AlgalarrondoWalid AmaraAbdeslam BouzemanEstelle GandjbakhchNicolas LelloucheJules LouembeAymeric MenetPierre RoumegouFrederic TreguerAnne GodierSerge BovedaRodrigue GarciaEloi MarijonPublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2023)
In this large real-life registry where most patients had DOAC interruption, clinically relevant haematoma was rare. Despite DOAC interruption and high CHA2DS2-VASc score, thromboembolic events occurred seldomly, highlighting that bleeding exceeds thromboembolic risk in this peri-procedural period. Future research is needed to identify risk factors for clinically relevant haematoma and meaningfully guide clinicians in optimizing DOAC management.